Hualan Biological Vaccine Inc. (SHE:301207)

Hualan Biological Vaccine Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Cash & Equivalents	490.19	623.04	640.98	600.04	131.56	412.39
Short-Term Investments	1,092	1,145	373.46	130	-	-
Trading Asset Securities	1,709	1,458	1,599	1,419	825.82	452.86
Cash & Short-Term Investments	3,291	3,227	2,613	2,149	957.39	865.25
Cash Growth	-2.28%	23.48%	21.57%	124.50%	10.65%	72.84%
Accounts Receivable	1,278	1,438	1,990	1,796	1,439	1,530
Other Receivables	0.58	0.41	1.31	0.41	2.15	2.18
Receivables	1,278	1,438	2,412	1,856	1,441	1,532
Inventory	313.5	208.84	173.47	167.16	107.41	45.27
Other Current Assets	175.21	103.13	28.18	20.22	23.31	22.86
Total Current Assets	5,058	4,977	5,227	4,193	2,529	2,465
Property, Plant & Equipment	1,037	1,071	1,176	1,287	1,351	810.97
Long-Term Investments	-	1,204	1,296	1,310	356.3	-
Other Intangible Assets	20.68	20.88	20.13	20.78	21.43	22.08
Long-Term Deferred Tax Assets	208.49	212.73	217.97	208.56	182.9	170.41
Long-Term Deferred Charges	27.86	27.79	27.94	28.69	33.36	19.58
Other Long-Term Assets	1,090	11.05	30.61	27.98	48.93	159.61
Total Assets	7,443	7,523	7,995	7,076	4,523	3,648
Accounts Payable	101.82	81.78	116.76	125.67	185.5	105.46
Accrued Expenses	-	903.53	1,155	1,050	929.48	956.07
Short-Term Debt	300	300.18	300.18	300.18	500.44	200
Current Portion of Leases	-	-	-	-	1.03	-
Current Income Taxes Payable	1.57	-	50.81	9.24	15.99	154.44
Current Unearned Revenue	12.86	8.74	2.67	2.68	1.54	1.89
Other Current Liabilities	935.93	169.9	60.63	49.13	38.19	36.74
Total Current Liabilities	1,352	1,464	1,686	1,537	1,672	1,455
Long-Term Leases	-	-	-	-	0.81	-
Long-Term Unearned Revenue	26.13	27.19	31.42	35.66	39.89	6
Long-Term Deferred Tax Liabilities	17.13	18.8	15.22	6.41	2.5	0.28
Total Liabilities	1,395	1,510	1,732	1,579	1,715	1,461
Common Stock	601.03	601.03	600.02	400.01	360	360
Additional Paid-In Capital	2,928	2,926	2,915	3,089	879.79	879.79
Retained Earnings	2,626	2,593	2,748	2,008	1,568	947.34
Treasury Stock	-106.79	-106.79	-	-	-	-
Shareholders' Equity	6,048	6,013	6,263	5,497	2,808	2,187
Total Liabilities & Equity	7,443	7,523	7,995	7,076	4,523	3,648
Total Debt	300	300.18	300.18	300.18	502.27	200
Net Cash (Debt)	2,991	2,926	2,313	1,849	455.12	665.25
Net Cash Growth	-2.51%	26.53%	25.07%	306.31%	-31.59%	32.89%
Net Cash Per Share	5.01	4.89	3.84	3.13	0.84	1.23
Filing Date Shares Outstanding	595	595	600.02	600.02	600.02	600.02
Total Common Shares Outstanding	595	595	600.02	600.02	540	540
Working Capital	3,706	3,512	3,541	2,656	857.07	1,011
Book Value Per Share	10.16	10.11	10.44	9.16	5.20	4.05
Tangible Book Value	6,027	5,992	6,243	5,476	2,787	2,165
Tangible Book Value Per Share	10.13	10.07	10.40	9.13	5.16	4.01
Buildings	-	376.55	376.55	376.19	375.5	169.91
Machinery	-	1,496	1,472	1,450	1,388	688.28
Construction In Progress	-	6.72	3.23	3.26	-	315.55

Updated Oct 29, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.